Mar 012023
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Skyclarys | omaveloxolone | 2/28/2023 | To treat Friedrich’s ataxia | Drug Trials Snapshots | |
| Filspari | sparsentan | 2/17/2023 | To reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression | Drug Trials Snapshot | |
| Lamzede | velmanase alfa-tycv | 2/16/2023 | To treat non-central nervous system manifestations of alpha-mannosidosis | ||
| Jesduvroq | daprodustat | 2/1/2023 | To treat anemia caused by chronic kidney disease for adults on dialysis for at least four months | Press Release | Drug Trials Snapshot |
Sorry, the comment form is closed at this time.